L.E.K. Consulting
Print button

Biopharmaceuticals & Life Sciences

Pharmaceutical Company Shifts Direction, Transforms into Industry Leader

The client, a mid-tier global pharmaceutical company, approached L.E.K. Consulting with an impending revenue “cliff” due to loss of patent exclusivity on a number of key products.
Yes

Specialty Pharma Company Wins Major Licensing Deal in Japan

An American specialty pharmaceutical company believed that there was significant opportunity in Japan for its drug that was still in clinical trials. However, the pharmaceutical company lacked a presence in Japan, and required a partner for market access and success.
No

Strategic Plan Generates Market Leading Global Molecular Diagnostics Company

L.E.K. has helped a molecular diagnostics company develop a five-year strategic plan and establish itself as a global market leader.
No

Bellwether Product Becomes Cornerstone of Pharmaceutical Company's Long-Term Success

Following positive clinical results, a global biopharmaceutical company engaged L.E.K. Consulting to help it develop a product launch strategy for a next generation biopharmaceutical drug.
No

Biotechnology Company Finds Formula to Become a Global Market Leader

For more than 20 years L.E.K. Consulting has been a trusted advisor to a leading global biotechnology company in R&D, business development, strategic planning and global marketing. L.E.K.’s relationship with this client grew out of the Boston office in the early 1990s and has since expanded to include international engagements in both mature and emerging markets.
No

100-Day Plan Lays Foundation for Portfolio Company's Post-Acquisition Success

After enlisting L.E.K. Consulting to provide commercial due diligence on a pharmaceutical company, a U.K. private equity (PE) firm acquired the corporation. The global PE firm again turned to L.E.K. to lead the post-acquisition work for the U.S.-based company, and immediately enhance the value of its new portfolio company.
No